Evaluation of a Virtual Reality-based Version of the Multiple Errands Test in Alcohol Use Disorder (NCT07593664) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Evaluation of a Virtual Reality-based Version of the Multiple Errands Test in Alcohol Use Disorder
France90 participantsStarted 2026-05
Plain-language summary
The goal of this study is to validate the virtual version of the Multiple Errands Test (V-MET) as a tool for assessing executive functions in patients with alcohol use disorder (AUD).
More specifically, the project aims to:
1. evaluate if the performance in the virtual version of the test is related to the performance in the original test in patients with AUD.
2. establish whether the virtual version of the test is sensitive enough to detect patients with or without an executive function deficit.
All participants will perform the original version (in a real-life supermarket) and the virtual version of the test (in a virtual reality environment).
Performance in the two versions of the test will be compared. Participants will also complete a battery of neuropsychological tests and questionnaires.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* written consent
* Normal or corrected vision and hearing
* Membership or entitlement to a social security plan
* spoken and written French
* third party liability insurance
for patients only :
* at least 6 criteria for AUD based on the Diagnostic and statistical manual of mental disorders
* At the end of withdrawal: treatment with a diazepam equivalent of ≤ 20 mg/day
Exclusion Criteria:
* under tutorship/ judicial protection
* Sensory or motor impairment (impeding the use of virtual reality and/or mobility)
* Severe neurological disorder (such as dementia or Korsakoff's syndrome)
* Photosensitive epilepsy (contraindication for the use of virtual reality)
* Any other condition deemed incompatible with the study, at the investigator's discretion
* Montreal Cognitive Assessment (MoCA) score \< 10 (severe cognitive impairment)
* Breastfeeding or pregnant women
* Familiarity with the supermarket visited during the MET test
For controls only :
* History of alcohol use disorder
* score ≥ 8 on the Alcohol Use Disorders Identification Test
* Score on the Frontal Assessment Battery \< 16 (or \< 15 if education is below secondary level)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.